Drawing for PHARMAVIDIN

USPTO serial 79117580

PHARMAVIDIN

Reviewed by CopyMark Law Group

Reg. 4405135Status 404
Filing date
Status date
Registration date
Sep 24, 2013
Examiner
GLASSER, CARYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARMAVIDIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Burton S. Ehrlich

Burton S. Ehrlich Ladas & Parry LLP224 S. Michigan AvenueSuite 1600Chicago, IL 60604

Goods and services

ClassDescriptionStatusFirst use
005Medical and pharmaceutical substances, namely, enzymes and proteins for medical purposes being a component in diagnostic preparations for medical or pharmaceutical use for treatment of viruses and tumors and as a component in medication for anti-viral and anti-tumoral preparations; protein-based pharmaceutical preparations for targeting treatment agents to specific sites; active medical substances, namely, enzymes and proteins for medical purposes being a component in the composition of diagnostic preparations for medical or pharmaceutical use and in the preparation of medication for treatment of viruses and tumorsSECTION 71 - CANCELLED—
035Wholesale and retail stores services, and mail-order services featuring medical and pharmaceutical substances used in the composition of diagnostic preparations for medical or pharmaceutical use and in the preparation of medication of anti-viral and anti-tumoral preparations; presentation of goods via any communications means, namely, conducting of products presentation for retail purposes in the field of diagnostic preparations for medical or pharmaceutical use and in the field of medication and other anti-viral and anti-tumoral preparations; business administration of licenses relating to medical and pharmaceutical substances used in the composition of diagnostic preparations for medical or pharmaceutical use and in the preparation of medication of anti-viral and anti-tumoral preparations; dissemination of advertising and promotional materials, namely, pamphlets, catalogs, prints, and samples in the medical or pharmaceutical fieldsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and design services relating thereto in the field of the extraction of medical and pharmaceutical substances used in the composition of diagnostic preparations for medical or pharmaceutical use and in the preparation of medication of anti-viral and anti-tumoral preparations; industrial analysis and scientific research in the field of the extraction of medical and pharmaceutical substances used in the composition of diagnostic preparations for medical or pharmaceutical use and in the preparation of medications, anti-viral and anti-tumoral preparations; design and development of computer software relating to the medical or pharmaceutical fields; research and development of testing, detection and diagnostic apparatus and instruments for medical or veterinary useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 13, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 13, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 29, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 29, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 29, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 5, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Sep 24, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 2, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 2, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 24, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 24, 2013FIMPFINAL DISPOSITION PROCESSED—
Dec 24, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 24, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2013GPNXNOTIFICATION PROCESSED BY IB—
Jul 9, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 19, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 19, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 5, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 5, 2013ALIEASSIGNED TO LIE—
May 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 17, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 11, 2012RFNTREFUSAL PROCESSED BY IB—
Nov 16, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 16, 2012RFRRREFUSAL PROCESSED BY MPU—
Nov 15, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2012DOCKASSIGNED TO EXAMINER—
Oct 5, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 1, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance